Investing analyses

# ROOT — Earnings Review Q3 FY25 (Atlas)

> Date: 2026-02-23
> Quarter: Q3 FY25 (quarter ending Sep-2025)
> Market cap: ~$1.0B | EV/TTM Rev: ~0.7x | Revenue growth: +26.9% YoY

---

## Verdict

Root delivered record quarterly revenue ($387.8M) and policies in force (466,320) but the underlying profit picture deteriorated sharply: operating income collapsed from $27.3M in Q2 to $0.3M, a $17M Carvana warrant expense (of which $15.5M was cumulative catch-up) drove a $5M net loss, and combined ratios crossed back above 100%. Revenue growth is decelerating for the third consecutive quarter (37.1% → 32.4% → 26.9% YoY). The technology moat narrative remains credible on the surface — 20% LTV improvement, 10% UVI uplift — but telematics is now industry-table-stakes and the Q3 numbers show this is not a clean compounder. Q4 reacceleration data (October PIF "definitely accelerated") is the make-or-break test. **Conviction: 2/5.** Insurance framework applies — standard growth thresholds are not directly comparable, but the deceleration trend is real regardless of framework.

---

## Qualification Gate

| Criterion | Threshold | Actual | Pass/Fail |
|-----------|-----------|--------|-----------|
| Revenue YoY growth | >30% | 26.9% | **FAIL** |
| Gross margin | >60% (GAAP) | 38.3% GAAP / 21.0% mgmt | **FAIL** — insurance cost structure |
| Revenue per quarter | >$50M | $387.8M | PASS |
| Data availability | 4+ quarters | 12 quarters | PASS |
| Share dilution | <10% annual | <5% (basic: 15.4M, diluted anti-dilutive Q3) | PASS |
| GAAP profitability trajectory | Improving | Q3 net loss $5M (warrant-driven); YTD NI $35M | CONDITIONAL |

**Gate note:** ROOT is an insurance company. The standard SaaS/tech gate thresholds do not directly apply. Gross margin in insurance reflects claims + LAE vs. premium revenue — structurally lower than software. Applying the gate mechanically produces fails that are artifacts of sector, not business quality. The revenue growth fail (26.9% vs 30% thres

*…truncated*

# ROOT — Stock Analysis
**wsm007 | February 25, 2026 | Based on Q3_FY25 (Sep-2025)**

---

## Verdict

**WAIT.** Q4_FY25 reports tonight (Feb 25, 2026 after close) and it is the binary test of this thesis. I will not take a position before seeing those numbers. The Q3 data alone has enough yellow flags that buying here is speculation, not conviction.

---

## Prior View

Dec 2024 — I was "cautiously for ROOT." The thesis was PIF growth in the target market. Since then, the business has delivered mixed evidence. Let me rerun the tape with Q3_FY25 in hand.

---

## Revenue Trajectory

### Same-Quarter QoQ Comparison

| | Q3_FY22 | Q3_FY23 | Q3_FY24 | Q3_FY25 |
|---|---|---|---|---|
| Revenue ($M) | 73.7 | 115.3 | 305.7 | 387.8 |
| QoQ % | -8.3% | +54.1% | +5.7% | **+1.3%** |
| YoY % | — | — | +165.1% | +26.9% |

Q3 sequential growth has collapsed: 54% → 5.7% → 1.3%. At 1.3% QoQ, revenue is barely moving.

### YoY Trend (Primary Signal)

| | Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 |
|---|---|---|---|---|
| YoY % | 67.7% | 37.1% | 32.4% | **26.9%** |

Three consecutive quarters of YoY deceleration. In my SaaS framework, two is the sell trigger. This is not SaaS — but a decelerating growth trend in any business is a yellow flag, not a green one.

**Partial mitigation:** Q2 was distorted by ROOT proactively lowering rates in Florida (double-digit rate cut). This compressed earned premium in Q2–Q3 due to the lag between written and earned. The true underlying GPW trajectory is less alarming.

### Gross Premiums Written — the Real Leading Indicator for Insurance

| | Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 |
|---|---|---|---|---|
| GPW ($M) | 330.5 | 410.8 | 346.2 | 387.2 |
| QoQ % | — | +24.3% | -15.7% | +11.8% |

GPW recovered nicely in Q3 after the Florida-driven Q2 dip. Q1 GPW ($410.8M) was strong — driven by the new pricing model. Q3 GPW ($387.2M) is growing 16.7% YoY vs Q3_FY24 ($331.7M). That's not exciting but it's stable.

---

## Policies in Force — Leading Indicator 

*…truncated*

# ROOT — Earnings Review Q4 FY25

> Bear (PaulWBryant) | April 1, 2026
> Quarter ending: Dec-2025 | Reported: Feb 25, 2026
> Market cap: ~$0.96B | P/S: 0.61x | Revenue: $397.0M (+21.5% YoY)

---

## Verdict

Root delivered record revenue ($397M), record PIF (481,869), and returned to net profitability ($5.3M) after Q3's warrant-driven loss. Management kept every single Q3 promise — all eight — which earns real credibility. FY2025 was a genuine milestone: $1.5B revenue, $40M record net income, and $192M free cash flow for a company that nearly went bankrupt three years ago.

But the numbers beneath the surface are telling a more complicated story. Revenue growth decelerated for the fifth consecutive quarter (21.5%, down from 67.7% five quarters ago). All three GAAP margins compressed YoY. The gross accident-period loss ratio inflected upward to 62.8% — the worst reading in a year. Premium per policy declined YoY for the first time in available history. And management proactively guided for *lower* net income in 2026 as they enter a deliberate reinvestment cycle.

This is not a broken company — far from it. But it's a company where the theory ("AI-driven pricing creates a structural compounding advantage") hasn't yet matched the recent numbers (decelerating growth, compressing margins, rising loss ratios). I could be wrong — and the valuation at 0.6x P/S means the market is pricing in a lot of the risk already — but I need to see the 2026 investment phase actually produce reacceleration before I can build conviction.

**Thesis: Watchlist — Interesting but unproven at this stage of the cycle.**

---

## Prior Beliefs / Updated Beliefs

This is my first formal ROOT analysis. I'm constructing reasonable expectations based on Q3 FY25 data, management's Q3 promises, and the trajectory.

| Metric | Prior Belief (pre-Q4) | Actual Q4 FY25 | Verdict |
|--------|----------------------|----------------|---------|
| Revenue | $395-405M (+22-25% YoY) | $397.0M (+21.5% YoY) | **In 

*…truncated*

# ROOT — Earnings Review Q4 FY25 (Saul)

> Date: 2026-04-06
> Quarter: Q4 FY25 (quarter ending Dec-2025)
> Market cap: ~$0.96B | P/S: 0.61x | Revenue growth: +21.5% YoY
> Atlas baseline: Q3_FY25 review (2/5 conviction)

---

## Verdict

Let me cut right to it. ROOT delivered a fifth consecutive quarter of revenue growth deceleration — 37.1% to 32.4% to 26.9% to 21.5%. Full stop. That's the headline. Revenue hit a record $397M, policies in force hit a record 482K, and FY25 net income hit a record $40M. Those are all nice. But I follow the trajectory, and the trajectory is going the wrong direction.

Now, I have to be honest with myself — this is an insurance company, not a SaaS company. A $1.5 billion auto insurer growing 21% while producing $192M in free cash flow and $40M in net income is, objectively, a good business. It's just not the *kind* of business I'm best at evaluating. The combined ratios, loss reserves, earned premium vs. written premium lags, seasonal severity patterns — this is a different animal from the high-growth software companies I've spent decades analyzing.

What really concerns me is management explicitly guiding to **lower** net income in 2026. That's "investing for the future" language, and I've seen enough of those to know it's often a code phrase for "results are going to be worse." The accident period loss ratio has deteriorated from 55.5% to 62.8% over four quarters — that's not a rounding error, that's a trend. Premium per policy is declining for the first time YoY ($1,531 vs $1,584). And competition in auto insurance — well, let's just say Progressive isn't sitting still.

The bull case rests on the independent agent channel (tripled YoY, only ~10% penetrated nationally) and the embedded distribution model (Carvana, Toyota, Hyundai, Experian). These are genuinely differentiated. The valuation at 0.61x P/S is absurdly cheap if the growth story holds. But cheap stocks can stay cheap if growth keeps decelerating.

**My verdict: Mixed quar

*…truncated*

# ROOT — Q4 FY25 Earnings Review (StockNovice)

> Date: 2026-04-06
> Quarter: Q4 FY25 (Dec-2025) | Reported: 2026-02-25
> Market cap: ~$1.0B | P/S: 0.6x | Revenue growth: +21.5% YoY

---

## The Bottom Line

Here's how I'm thinking about Root after Q4. This is a company that just wrapped up its first full year of profitability — $40M net income, $192M free cash flow, $1.5B in revenue — and the market is valuing it at 0.6x sales. That's a number you typically see on companies bleeding cash with no path forward. Root is neither of those things.

But — and there's always a but — the growth trajectory is clearly decelerating, the accident-period loss ratio has gotten worse four quarters straight, and management just told you they're going to make less money in 2026 than they did in 2025. On purpose. So the question isn't "is Root a real company?" — it clearly is. The question is whether the investment in growth levers will reaccelerate the business or whether we're watching a company mature into a slow-growth insurer at a sub-500K PIF base.

I come down on the optimistic side, but not without reservations.

---

## Prior Beliefs / Updated Beliefs

This is my first deep dive on ROOT, so I'm building beliefs from scratch. I've read Atlas's Q3 analysis (which called it 2/5 conviction) and Bear and Saul's Q4 updates to the rolling file. Let me set my priors based on Q3 context heading into Q4:

| Metric | Expected (pre-Q4) | Actual | Verdict |
|--------|-------------------|--------|---------|
| Revenue | $395-405M (+22-25% YoY) | $397.0M (+21.5%) | **In-line** — slightly lower on growth rate |
| QoQ revenue add | $8-15M (above Q3's paltry $4.9M) | +$9.2M (+2.4% QoQ) | **In-line** — modest rebound from Q3 stall |
| PIF | 475-490K (acceleration promised) | 481,869 (+3.3% QoQ, +16.2% YoY) | **Met** — >2x Q4 FY24 pace as promised |
| Net income | $5-15M (investment ramp + seasonality) | $5.3M | **Low end** — deliberate spend + loss ratio |
| Combined ratio | 98-101% (seasonal h

*…truncated*